Key statistics
On Friday, Alkermes Plc (8AK:DEU) closed at 26.40, -13.16% below its 52-week high of 30.40, set on Feb 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 26.80 |
---|---|
High | 26.80 |
Low | 26.00 |
Bid | 26.40 |
Offer | 27.40 |
Previous close | 26.80 |
Average volume | 10.00 |
---|---|
Shares outstanding | 161.80m |
Free float | 159.66m |
P/E (TTM) | 9.78 |
Market cap | 4.67bn USD |
EPS (TTM) | 2.95 USD |
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Press releases
- Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences
- Alkermes plc Reports Third Quarter 2024 Financial Results
- Alkermes to Report Third Quarter Financial Results on October 24, 2024
- Alkermes to Host Investor Event to Review Orexin Portfolio Strategy
- Alkermes to Present Positive Clinical Data From Phase 1b Study of ALKS 2680 in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia at Sleep Europe 2024
- Alkermes to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Conference
- Alkermes Announces Launch of 7th Annual Alkermes Pathways Research Awards® Program
- Alkermes to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- Alkermes Announces Initiation of Vibrance-2 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 2
More ▼